George Mason University employs rapid-result COVID-19 tests to control the spread of virus on campus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
The adjustable tip spacing pipettes from INTEGRA are used to increase efficiency in the production of venom-based screening assays
CryoLogyx will use research emerging from Professor Gibson’s laboratories to transform how cells, and cell-based therapies are stored and transported
RNA controls can help avoid false negative results
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing
Digital PCR for COVID-19 wastewater testing overcomes limitations of traditional PCR
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
The company’s most significant advance in chromatography since UPLC aims to accelerate scientific research and development
This highly sensitive, cost effective assay is designed for customers who receive a high volume of food samples daily